| No |
Role |
Company |
Company Address |
Dates Employed |
Employment Duration |
| 1 |
Senior Director, Alliance Management & Program Lead |
Halozyme Therapeutics, Inc. |
Greater San Diego Area |
Jul 2018–Present |
2 yrs 11 mos |
| 2 |
President |
Toastmasters International - Pfluently Pfizer- District 5 |
San Diego, California |
Oct 2016–Jun 2018 |
1 yr 9 mos |
| 3 |
Associate Director of Oncology R&D Alliance Management |
Pfizer |
Greater San Diego Area |
Mar 2012–Jun 2018 |
6 yrs 4 mos |
| 4 |
Business Operations & External Alliance Management, Oncology Research Unit |
Pfizer |
Greater San Diego Area |
Mar 2012–Dec 2015 |
3 yrs 10 mos |
| 5 |
Global Risk Management Project Lead - Pfizer Medical Division |
Pfizer |
La Jolla, CA |
Mar 2011–Dec 2011 |
10 mos |
| 6 |
Business Operations Manager, Oncology Research Unit- La Jolla |
Pfizer |
Greater San Diego Area |
Sep 2010–Feb 2011 |
6 mos |
| 7 |
Business Operations Manager, Comparative Medicine- Cambridge, MA |
Pfizer |
|
Apr 2010–Sep 2010 |
6 mos |
| 8 |
Business Operations Manager, Comparative Medicine- La Jolla, CA |
Pfizer |
|
Oct 2009–Apr 2010 |
7 mos |
| 9 |
Startup Technology Venture Co-Founder |
3D Navigo |
|
Mar 2006–Aug 2009 |
3 yrs 6 mos |
| 10 |
Registered Associate |
UBS Financial Services |
San Francisco Bay Area |
Feb 2008–Dec 2008 |
11 mos |
| 11 |
MBA Corporate Research Project |
VeriSign |
Mountain View, California |
Oct 2005–Jun 2006 |
9 mos |
| 12 |
Associate Investment Advisor |
TD Waterhouse |
Toronto, Canada Area |
Nov 2004–May 2006 |
1 yr 7 mos |
| 13 |
MBA Corporate Research Projects |
First Wilshire Securities Management, Inc. |
Pasadena, California |
Aug 2005–Mar 2006 |
8 mos |
| 14 |
MBA Corporate Research Project |
Hanfeng Evergreen |
Toronto, Canada Area |
Jun 2005–Sep 2005 |
4 mos |
| 15 |
Business Development & Financial Planning Associate |
Raymond James Ltd. |
Toronto, Canada Area |
Nov 2001–Nov 2004 |
3 yrs 1 mo |
| 16 |
Marketing & Client Relations Associate |
Merrill Lynch |
Toronto, Canada Area |
Nov 1998–Nov 2001 |
3 yrs 1 mo |